Q: Last week, Resverlogix received a positive confirmation from the FDA that it would likely support approval of BETon MACE based on the result of its Phase 3 study.  The stock moved up ~28% today.  It shows great promise in treating types of cardiovascular disease.  From your experience, is it normal for the FDA to offer a positive comment?  Would you have an opinion based on the FDA comment to open a position?  I am a prudent investor yet have room for higher risk opportunities.
Thank you
    Thank you